Study comparing the effects and side effects of milnacipran and pregabalin in patients with chronic pain condition known as fibromyalgia
Phase 4
- Conditions
- Health Condition 1: M797- FibromyalgiaHealth Condition 2: null- Patients diagnosed with fibromyalgia using modified ACR 2010 criteria
- Registration Number
- CTRI/2017/03/008113
- Lead Sponsor
- irmal George
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Subjects diagnosed as having fibromyalgia according to 2010 ACR diagnostic criteria for fibromyalgia
Exclusion Criteria
1.Subjects not willing to take part in the study.
2.Major depressive or psychiatric disorder, suicidal tendency or ideation.
3.Pregnancy
4.Lactation
5.Uncontrolled hypertension
6.Hepatic dysfunction
7.History of glaucoma
8.Patients receiving MAO inhibitors (eg: selegeline)
9.Cardiac failure (NYHA class III-IV)
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in modified Fibromyalgia Impact Questionnare (FIQR)score from baseline.Timepoint: 2 months, 3 months of treatment.
- Secondary Outcome Measures
Name Time Method